Monthly Newsletter

As the world’s third largest exporter for APIs, India has long been a key player in the global pharmaceutical scene. 

Over the last decade, India’s role has also further expanded, being identified as an ideal partner by multinational pharmaceutical companies for contract research and development activities.  

Despite the recent setback due to drug quality issues, the outlook of India’s pharmaceutical industry remains promising as the industry and government strive to strengthen its focus on manufacturing quality products.

The 13th edition of BioPharma India Convention returns with multiple tracks assembling key opinion leaders and industry stakeholders from across the globe.

Over the course of 2 days, opportunities and strategies to overcoming challenges in India’s biopharma industry will be outlined. Latest technologies will also be presented and assessed by industry experts.

For technology and solution providers in the biopharma industry, this is the event that will help you meet your business priorities with its interactive agenda and dedicated one-to-one partnering opportunities.

For further information click here